OptiBiotix to showcase range of microbiome modulating ingredients at the 2022 IFT FIRST Annual Event and Expo.

Photo © AdobeStock.com/BillionPhotos.com

OptiBiotix Health Plc will be showcase its microbiome modulating ingredients at this year’s IFT FIRST Event and Expo taking place at McCormick Place in Chicago from July 11-13, 2022. These ingredients include its weight management ingredient SlimBiome, its newly launched sports nutrition ingredient LeanBiome, and its health and wellness focused ingredient WellBiome. Additionally, the company will be showing its patented probiotic strain, LPLDLand its finished product ranged called CholBiome, from ProBiotix Health Plc, each of which are designed to support heart health.

“With just over half (59%) of global consumers wanting to see demonstrable, scientific proof of efficacy in nutritional supplements1, our range of microbiome modulators are exactly what many US brands are looking for today,” said Zac Sniderman, director of business development, North America at OptiBiotix, in a press release. “Exhibiting at IFT FIRST offers OptiBiotix an unique opportunity to speak directly with industry professionals looking to expand their nutritional range to meet consumer demand with scientifically backed ingredients.

“From our weight management ingredient SlimBiome to our patented probiotic strain LPLDL, our solutions offer excellent benefits to support general health and wellbeing. If you are looking for a truly innovative prebiotic or probiotic formulation for your next nutritional application, come visit us at Stand S1471 and our team will be more than happy to discuss your requirements.”